Directive No. 05/2004/CT-BYT of the Minister of Health stipulates measures to rectify the supply and use of medicines in hospitals to ensure the quality of medical examination and treatment and rational, safe drug use. The Directive applies to hospital directors, health department directors, department heads, bureau chiefs, chief inspectors of the Ministry of Health, institute directors, sub-institute directors, and directors of pharmaceutical and cosmetic testing centers.
适用范围
Hospital directors, health department directors of centrally-administered cities and provinces, department heads, bureau chiefs, chief inspectors of the Ministry of Health, institute directors, sub-institute directors, and directors of pharmaceutical and cosmetic testing centers.
要点
- Hospital directors → ensure sufficient essential medicines according to the Essential Medicine List, tender for medicine procurement, implement the Ministry of Health's regulations on medicine prices, direct the Medicine and Treatment Council, organize the distribution of medicines, inspect prescription writing and medicine sales.
- Health department directors → guide, direct, and inspect medicine procurement tenders, conduct inspections on the implementation of prescription writing and medicine sales according to prescriptions within their jurisdiction.
- Department heads, bureau chiefs, chief inspectors of the Ministry of Health → provide guidance and direction for hospitals to use medicines rationally and safely, develop guidelines for medicine procurement tenders, organize inspections of medicine buying and selling activities, implement regulations on prescription writing and medicine sales according to prescriptions.
- Institute directors, sub-institute directors, directors of pharmaceutical and cosmetic testing centers → strengthen inspections and supervision of medicine quality at hospitals.
- Hospital directors → strictly prohibit selling medicines within hospitals and linking with healthcare staff to sell medicines; influencing prescription writing to receive kickbacks.
🌐 本文件的社会影响
- Positive impact: Ensuring the quality of medical examination and treatment, rational and safe use of medicines.
- Negative impact: Management and organizational burden on hospital directors and health departments.
❓ 常见问题
What responsibilities does the hospital director have?
The hospital director must ensure sufficient essential medicines according to the Essential Medicine List, tender for medicine procurement, implement the Ministry of Health's regulations on medicine prices, direct the Medicine and Treatment Council, organize the distribution of medicines, inspect prescription writing and medicine sales.
What responsibilities does the health department director have?
The health department director must guide, direct, and inspect medicine procurement tenders of hospitals under the health department; organize inspections of medicine procurement tenders, prescription writing, and medicine sales according to prescriptions within the local area.
Which actions are strictly prohibited?
Individuals, departments, and units are not allowed to sell medicines within hospitals; pharmaceutical business establishments and individuals introducing medicines are not allowed to link with healthcare staff to sell medicines within departments, units, and hospitals; influencing prescription writing to receive kickbacks.
What effects does this rectification have?
Positive impacts include ensuring the quality of medical examination and treatment and rational, safe use of medicines. Negative impacts include management and organizational burdens on hospital directors and health departments.
Are there specific regulations regarding medicine prices at hospital pharmacies?
Medicine prices at hospital pharmacies shall not be higher than retail prices on the local market at the same time period.
全文
DIRECTIVE OF THE MINISTER OF HEALTH
On regulating the supply and use of medicines in hospitals
_______________________________________
In recent times, medical examination and treatment facilities (hereinafter referred to collectively as hospitals) have made significant efforts in supplying medicines to patients, especially from 1997 onwards, the Hospital Pharmacy and Treatment Councils have been actively operating, contributing to providing sufficient quality-assured medicines and rational, safe medicine usage, thereby improving the quality of treatment. However, many hospitals still fail to ensure adequate supply of essential medicines, inpatient patients must purchase their own medicines; hospital pharmacies have not strictly implemented the regulations of the Ministry of Health; they have not strictly adhered to Prescription Regulations and selling medicines based on prescriptions.
To regulate the supply of medicines to ensure the quality of medical examinations and treatments and rational, safe medicine usage, the Minister of Health issues the following directive:
1. The Director of the hospital shall be responsible for:
a) Ensuring sufficient essential medicines listed in the Medicine Directory for use at medical examination and treatment facilities, without allowing inpatients to purchase their own essential medicines. Organize bidding to purchase medicines according to the provisions of the law.
b) Ensuring all activities of the hospital pharmacy comply with the regulations issued by the Ministry of Health. The price of medicines at the hospital pharmacy shall not be higher than the retail price of medicines on the local market at the same time.
c) Directing the operation of the Hospital Pharmacy and Treatment Council in selecting and rationally using medicines safely. Strengthening the inspection of prescription regulations and selling medicines based on prescriptions within the hospital.
d) Organizing the distribution of medicines to clinical departments; promoting the role of the drug information unit in the hospital.
đ) Strictly prohibiting the following actions:
Individuals, departments, and rooms selling medicines within the hospital.
Pharmaceutical business establishments and drug promoters (pharmaceutical representatives) colluding with healthcare staff to sell medicines in departments and rooms within the hospital; influencing prescription writing to receive commissions.
e) Strictly implementing the regulations on drug and cosmetic advertising directly affecting human health.
2. The Director of the Health Department of provinces and centrally-administered cities shall be responsible for:
a) Guiding, directing, and inspecting the bidding process for purchasing medicines by hospitals under the Health Department.
b) Organizing inspections and checks on the implementation of bidding for purchasing medicines, prescription regulations, and selling medicines based on prescriptions within the jurisdiction. Cases of violation shall be handled according to the provisions of the law.
c) Inspecting the supply and use of medicines in state-owned, semi-state-owned, and private hospitals within the jurisdiction of the Health Department.
3. The Heads of Departments, Directors of Bureaus, and Chief Inspectors of the Ministry of Health shall be responsible for:
a) The Head of the Treatment Department guiding methods for checking prescription writing and medical records; coordinating with the Bureau of Drug Administration of Vietnam Male to guide and direct hospitals to implement rational and safe medicine usage;
b) The Head of the Planning and Finance Department serving as the lead, coordinating with relevant agencies to develop guidelines for bidding on medicines used in hospitals;
c) The Inspectorate of the Ministry of Health shall be responsible for directing and organizing inspections on the buying and selling of medicines, the implementation of prescription regulations, and selling medicines based on prescriptions nationwide; Directly inspecting hospitals under the Ministry of Health and hospitals of various sectors. Cases of violation shall be handled according to the provisions of the law.
4. The Director of the Institute of Testing, the Deputy Director of the Branch Institute of Testing in Ho Chi Minh City, the Director of the Drug and Cosmetic Testing Center in provinces and centrally-administered cities shall strengthen inspections and supervision of the quality of medicines in hospitals.
Upon receipt of this Directive, the Heads of the Treatment Department, the Planning and Finance Department, the Director of the Bureau of Drug Administration of Vietnam, the Chief Inspector of the Ministry, the Secretary-General of the Ministry, the Heads of units under the Ministry, the Directors of Health Departments of provinces and centrally-administered cities, the Heads of health services of various sectors, shall promptly implement the Directive and report the results of its implementation to the Ministry of Health (Treatment Department)./
关系图
点击文件即可打开。红色边框＝改变效力的关系。